Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation ESC 2024

BedMed and BedMed-Frail randomized controlled trials

Presenter: Scott Garrison

August 31, 2024

Presentation NY Valves 2024

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Presenter: Bassem M. Chehab

June 07, 2024

Presentation AHA 2023

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

Presenter: Alexander C. Fanaroff

November 13, 2023

Presentation TCT 2023

TCT 158: The Impact of Sex And Age On Long-term Outcome After Percutaneous Coronary Interventions – A Pooled Analysis Of The Randomized Controlled SORT OUT Trials

Presenter: Emil Holck

October 26, 2023

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

Presentation TCT 2017

Trial In the Pocket: Myheartcounts

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Alan C. Yeung

October 30, 2017

Presentation TCT 2017

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Making the EHR Useful For Research: ADAPTABLE

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Adrian F Hernandez

October 30, 2017

Presentation TCT 2017

Keeping It Simple: Large Pragmatic Trials

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2016

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Jaya Chandrasekhar

October 31, 2016

Presentation TCT 2016

The Smoker's Paradox Revisited: A Five-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials

Presenter: Mayank Yadav

October 30, 2016

Advertisement

BedMed and BedMed-Frail randomized controlled trials

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

TCT 158: The Impact of Sex And Age On Long-term Outcome After Percutaneous Coronary Interventions – A Pooled Analysis Of The Randomized Controlled SORT OUT Trials

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Trial In the Pocket: Myheartcounts

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Making the EHR Useful For Research: ADAPTABLE

Keeping It Simple: Large Pragmatic Trials

The Inflammatory Hypothesis After CANTOS: CIRT

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Should Alleviating ISCHEMIA Be the Goal?

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials

The Smoker's Paradox Revisited: A Five-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content